Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
15.24
Dollar change
-0.05
Percentage change
-0.33
%
IndexRUT P/E6.98 EPS (ttm)2.18 Insider Own1.27% Shs Outstand63.23M Perf Week1.67%
Market Cap963.63M Forward P/E15.55 EPS next Y0.98 Insider Trans-1.35% Shs Float62.43M Perf Month-0.72%
Income179.72M PEG0.36 EPS next Q0.17 Inst Own116.24% Short Float20.85% Perf Quarter-6.33%
Sales324.26M P/S2.97 EPS this Y-63.18% Inst Trans-2.50% Short Ratio19.15 Perf Half Y15.72%
Book/sh10.66 P/B1.43 EPS next Y20.99% ROA14.52% Short Interest13.02M Perf Year33.92%
Cash/sh3.06 P/C4.98 EPS next 5Y19.34% ROE28.97% 52W Range11.11 - 16.86 Perf YTD-4.99%
Dividend Est.- P/FCF6.85 EPS past 5Y- ROI16.01% 52W High-9.64% Beta0.57
Dividend TTM- Quick Ratio7.96 Sales past 5Y-13.90% Gross Margin75.84% 52W Low37.17% ATR (14)0.33
Dividend Ex-DateSep 08, 2015 Current Ratio9.03 EPS Y/Y TTM-9.93% Oper. Margin35.12% RSI (14)52.76 Volatility1.58% 2.50%
Employees101 Debt/Eq0.67 Sales Y/Y TTM-6.05% Profit Margin55.42% Recom3.00 Target Price15.00
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q177.63% Payout0.00% Rel Volume0.72 Prev Close15.29
Sales Surprise13.67% EPS Surprise230.43% Sales Q/Q28.90% EarningsFeb 29 AMC Avg Volume679.95K Price15.24
SMA201.90% SMA50-2.05% SMA2007.98% Trades Volume490,248 Change-0.33%
Date Action Analyst Rating Change Price Target Change
Jul-20-22Initiated Goldman Neutral $16
Nov-20-17Initiated Deutsche Bank Hold $13
Mar-04-24 04:01PM
Feb-29-24 04:56PM
04:37PM
04:05PM
Feb-14-24 02:44AM
06:16PM Loading…
Jan-10-24 06:16PM
Nov-18-23 07:03AM
Nov-03-23 06:00AM
Nov-01-23 05:32PM
04:15PM
04:05PM
Sep-19-23 08:30AM
Sep-18-23 08:00AM
Aug-25-23 04:52PM
Aug-02-23 05:18PM
04:05PM Loading…
04:05PM
Jul-23-23 09:22AM
Jul-11-23 08:53PM
08:00AM
Jul-06-23 11:33AM
Jun-26-23 01:27AM
Jun-21-23 08:00PM
Jun-07-23 08:30AM
Jun-06-23 04:05PM
May-24-23 01:49PM
May-23-23 06:42PM
May-11-23 06:45PM
07:42AM
May-09-23 07:45PM
04:32PM
05:30PM Loading…
Apr-28-23 05:30PM
Apr-26-23 08:00PM
Apr-18-23 11:22AM
Apr-17-23 04:31PM
09:40AM
09:00AM
Apr-10-23 08:38AM
Apr-05-23 10:05AM
09:53AM
Apr-03-23 12:09PM
Mar-13-23 06:24PM
Feb-28-23 04:10PM
Feb-14-23 04:33PM
Feb-13-23 05:09AM
Jan-23-23 11:07AM
Jan-10-23 04:05PM
Jan-03-23 06:15PM
Dec-28-22 06:15PM
11:07AM
Dec-22-22 06:00PM
Dec-16-22 06:00PM
Nov-30-22 04:30PM
Nov-28-22 09:40AM
Nov-18-22 08:48AM
Nov-17-22 07:11AM
Nov-11-22 09:40AM
05:29AM
Nov-09-22 06:35PM
04:05PM
Oct-31-22 09:40AM
Oct-20-22 10:02AM
Oct-19-22 10:01AM
08:00AM
Oct-14-22 12:20PM
Oct-12-22 08:30AM
Sep-19-22 02:28PM
Sep-08-22 07:00AM
Sep-05-22 11:43AM
Aug-22-22 08:55AM
Jul-27-22 05:55PM
04:05PM
Jul-21-22 11:08AM
Jul-20-22 10:01AM
Jul-14-22 06:04PM
Jul-13-22 05:29PM
04:32PM
04:25PM
Jul-12-22 01:35PM
Jul-11-22 05:07PM
09:17AM
08:14AM
07:32AM
Jul-08-22 08:35AM
May-24-22 03:03PM
02:06PM
May-23-22 10:04AM
08:30AM
Apr-27-22 06:45PM
05:11PM
Apr-25-22 09:40AM
Apr-20-22 03:01PM
Apr-19-22 07:45AM
Apr-11-22 12:52PM
Apr-08-22 12:26PM
Apr-07-22 08:06AM
Apr-06-22 11:58AM
08:45AM
Apr-01-22 09:40AM
Mar-31-22 04:05PM
Mar-30-22 12:28PM
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhen MarianneChief Accounting OfficerNov 15 '23Sale13.9910,994153,81040,158Nov 17 04:30 PM
DENNER ALEXANDER J10% OwnerJun 06 '23Buy13.058,000104,3847,215,000Jun 07 08:10 PM
DENNER ALEXANDER J10% OwnerJun 05 '23Buy13.047,00091,2977,207,000Jun 07 08:10 PM
DENNER ALEXANDER J10% OwnerMay 30 '23Buy13.01120,0001,560,6487,200,000May 30 07:01 PM
DENNER ALEXANDER J10% OwnerMay 26 '23Buy13.1230,000393,7297,080,000May 30 07:01 PM
DENNER ALEXANDER J10% OwnerMay 25 '23Buy13.0950,000654,3307,050,000May 30 07:01 PM
DENNER ALEXANDER J10% OwnerMay 18 '23Buy13.0510,000130,5386,964,000May 19 08:00 PM
DENNER ALEXANDER J10% OwnerMay 17 '23Buy13.0750,000653,6906,954,000May 19 08:00 PM
DENNER ALEXANDER J10% OwnerMay 11 '23Buy12.34290,0003,577,4116,904,000May 15 09:09 PM